SHREVEPORT, La. - In 2011, Shane Sumlin's life changed overnight after being diagnosed with a rare neurological disorder called Guillain-Barre syndrome (GBS). It causes the body to attack its own ...
MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...
Please provide your email address to receive an email when new articles are posted on . Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals ...
Guillain-Barr syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are rare autoimmune conditions in which your immune system mistakenly ...
Lucknow neuro physiotherapist Dr. Akanksha Upadhyay presented a case study on Guillain-Barré Syndrome rehabilitation at AIIMS Delhi. Her research detailed an 8-week physiotherapy program that ...
As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. Alongside a clinical data ...
(WFSB) - What started as a few days of feeling sick suddenly led to a life-threatening diagnosis for Connecticut mom, Mariah Ferraiolo. The 24-year-old from Milford went from feeling under the weather ...